Laurion Capital Management’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-148,655
| Closed | -$919K | – | 217 |
|
|
2024
Q2 | $919K | Buy |
148,655
+26,218
| +21% | +$162K | 0.01% | 187 |
|
|
2024
Q1 | $622K | Sell |
122,437
-11,338
| -8% | -$57.6K | 0.01% | 244 |
|
|
2023
Q4 | $801K | Buy |
+133,775
| New | +$801K | 0.01% | 159 |
|
|
2017
Q4 | – | Sell |
-216,162
| Closed | -$1.13M | – | 1095 |
|
|
2017
Q3 | $1.13M | Buy |
+216,162
| New | +$1.13M | 0.01% | 510 |
|